CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 89 filers reported holding CARDIFF ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 2.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $545,458 | -2.6% | 392,307 | +2.9% | 0.00% | – |
| Q2 2023 | $560,290 | -17.9% | 381,150 | -7.8% | 0.00% | – |
| Q1 2023 | $682,278 | +117941.2% | 413,502 | 0.0% | 0.00% | – |
| Q4 2022 | $578 | -99.9% | 413,502 | -0.2% | 0.00% | – |
| Q3 2022 | $638,000 | -29.6% | 414,372 | +0.5% | 0.00% | – |
| Q2 2022 | $906,000 | -45.5% | 412,110 | -38.5% | 0.00% | – |
| Q1 2022 | $1,661,000 | -57.1% | 669,829 | +3.8% | 0.00% | – |
| Q4 2021 | $3,876,000 | -0.0% | 645,084 | +10.8% | 0.00% | -100.0% |
| Q3 2021 | $3,877,000 | +13.2% | 582,157 | +13.0% | 0.00% | – |
| Q2 2021 | $3,424,000 | +77.4% | 514,981 | +147.0% | 0.00% | – |
| Q1 2021 | $1,930,000 | -47.1% | 208,455 | +2.7% | 0.00% | -100.0% |
| Q4 2020 | $3,649,000 | +141.3% | 202,886 | +90.4% | 0.00% | – |
| Q3 2020 | $1,512,000 | +652.2% | 106,559 | +164.6% | 0.00% | – |
| Q2 2020 | $201,000 | – | 40,276 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 120,600 | $299,000 | 0.32% |
| Artal Group S.A. | 750,000 | $1,860,000 | 0.08% |
| Eventide Asset Management | 1,467,922 | $3,640,000 | 0.06% |
| Atom Investors LP | 33,798 | $84,000 | 0.04% |
| XTX Topco Ltd | 25,154 | $62,000 | 0.03% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 19,000 | $47,000 | 0.02% |
| Engineers Gate Manager LP | 245,567 | $609,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 63,749 | $158,000 | 0.02% |
| KENNEDY CAPITAL MANAGEMENT LLC | 168,902 | $419,000 | 0.01% |
| Walleye Capital LLC | 123,305 | $306,000 | 0.01% |